19th Annual Advanced Liver Disease and Liver Transplantation Update is organized by Michigan Medicine Office of Continuing Medical Education and Lifelong Learning and will be held on Apr 11, 2025 at Sheraton Detroit Novi Hotel, Michigan, United States of America.
Description:
This course will provide an update on recent developments in the management of patients with advanced liver disease including recent improvements in the medical management of steatotic liver disease, alcohol use disorder and alcoholic liver disease, and hepatic complications of heart disease. In addition, updates on acute on chronic liver failure, evaluation of substance use disorders in patients with advanced liver disease, liver transplantation for patients with metastatic colorectal cancer and neuroendocrine tumors, use of marginal organs in liver transplantation, and the medical management of long-term liver transplant recipients will be provided.
Objectives:
At the conclusion of this activity, learners will be able to:
Credit Designation:
AMA PRA Category 1 :
The University of Michigan Medical School designates this Live Activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC :
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Transplant Certification:
The American Board for Transplant Certification (ABTC) has approved this educational offering for up to 5.75 Category 1 Continuing Education Points for Transplant Certification (CEPTCs).
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved